ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 13, No. 4, April 2026 | pp. 246–252
DOI: 10.46882/AJIDR/148946
Article Type: Original Article
Title: Seroepidemiology and clinical spectrum of varicella-zoster virus reactivation and herpes zoster ophthalmicus in HIV-infected adults
Names of Authors: Fatou Sarr¹*, Jonathan Cooper², Rafael Silva³
Authors’ Affiliations: ¹Department of Dermatology and Venereology, Cheikh Anta Diop University, Dakar, Senegal. ²Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States. ³Oswaldo Cruz Foundation, Fiocruz, Rio de Janeiro, Brazil.
Abstract: Herpes zoster represents a frequent clinical indicator of cell-mediated immune decline and immune reconstitution inflammatory syndrome among people living with HIV. We evaluated incidence rates, anatomical dermatomes, and postherpetic neuralgia predictors among HIV-positive adults presenting with acute vesicular eruptions. Lesion swabs and blood samples from 245 patients were analyzed via real-time polymerase chain reaction and CD4 T-cell enumeration. Thoracic and trigeminal ophthalmic dermatomes accounted for 49.4 percent and 23.7 percent of cases, respectively. Early oral valacyclovir initiation within 72 hours significantly reduced ocular complications and chronic neuralgia.
Keywords: Varicella-zoster virus, Herpes zoster, HIV/AIDS, Postherpetic neuralgia, Antiviral therapy
Citation: Sarr F, Cooper J, Silva R (2026). Seroepidemiology and clinical spectrum of varicella-zoster virus reactivation and herpes zoster ophthalmicus in HIV-infected adults. African Journal of Infectious Diseases Research, 13(4): 246–252. DOI: 10.46882/AJIDR/148946
Manuscript Timeline: Received: February 27, 2026; Revised: March 29, 2026; Accepted: April 11, 2026; Published: April 18, 2026
Subscribe to read the full article: https://mail.internationalscholarsjournals.org/subscribe-to-read